Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02523794 · ClinicalTrials.gov registry record · NA
Study of Electro-kinetically Modified Water for the Treatment of Pain Associated With Endometriosis
A NA study, sponsored by Revalesio Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02523794 is a NA study that was terminated before completion, run by Revalesio Corporation. The registered enrollment target is 9 participants.
The verdict
NCT02523794, a NA study, was terminated before completion, sponsored by Revalesio Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of electro-kinetically modified water (EMW) beverage, consumed twice daily (BID) for 3 months in the management of endometriosis associated pain, and to evaluate the effect of EMW consumption on analgesic use for endometriosis associated pain.
Interventions
- OTHER Placebo
- OTHER Electro-kinetically Modified Water
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02523794
The ClinicalTrials.gov registry entry for NCT02523794 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Revalesio Corporation, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02523794 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02523794 about?
NCT02523794 is a clinical study titled "Study of Electro-kinetically Modified Water for the Treatment of Pain Associated With Endometriosis". The purpose of this study is to evaluate the efficacy of electro-kinetically modified water (EMW) beverage, consumed twice daily (BID) for 3 months in the management of endometriosis associated pain, and to evaluate the effect of EMW consumption on analgesic use for endometriosis associated pain.
What is the current status of trial NCT02523794?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2015-08. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02523794?
The interventions under investigation include: Placebo (OTHER), Electro-kinetically Modified Water (OTHER).
Who is sponsoring clinical trial NCT02523794?
This trial is sponsored by Revalesio Corporation, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.